SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 56 filers reported holding SPRING BK PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $24,000 | -29.4% | 26,213 | +22.9% | 0.00% | – |
Q4 2019 | $34,000 | -51.4% | 21,328 | +7.3% | 0.00% | – |
Q3 2019 | $70,000 | -4.1% | 19,869 | 0.0% | 0.00% | – |
Q2 2019 | $73,000 | -64.9% | 19,869 | 0.0% | 0.00% | – |
Q1 2019 | $208,000 | +1.0% | 19,869 | 0.0% | 0.00% | – |
Q4 2018 | $206,000 | – | 19,869 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 785,950 | $9,314,000 | 0.91% |
Morse Asset Management, Inc | 177,500 | $2,103,000 | 0.58% |
PARSONS CAPITAL MANAGEMENT INC/RI | 281,213 | $3,332,000 | 0.38% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 73,000 | $860,000 | 0.33% |
TIEDEMANN ADVISORS, LLC | 412,049 | $4,883,000 | 0.31% |
Private Capital Advisors, Inc. | 52,335 | $620,000 | 0.19% |
SECTORAL ASSET MANAGEMENT INC | 131,656 | $1,560,000 | 0.17% |
Lee Financial Co | 18,750 | $222,000 | 0.05% |
Baker Brothers Advisors | 373,144 | $4,422,000 | 0.03% |
Alyeska Investment Group, L.P. | 200,000 | $2,370,000 | 0.02% |